The latest closing stock price for Evogene as of September 18, 2024 is 2.74.
An investor who bought $1,000 worth of Evogene stock at the IPO in 2010 would have $-972 today, roughly -1 times their original investment - a -22.44% compound annual growth rate over 14 years.
The all-time high Evogene stock closing price was 199.90 on December 12, 2013.
The Evogene 52-week high stock price is 10.40, which is 279.6% above the current share price.
The Evogene 52-week low stock price is 2.72, which is 0.7% below the current share price.
The average Evogene stock price for the last 52 weeks is 6.57.
An investor who bought $1,000 worth of Evogene stock at the IPO in 2010 would have $-972 today, roughly -1 times their original investment - a -22.44% compound annual growth rate over 14 years.
The all-time high Evogene stock closing price was 199.90 on December 12, 2013.
The Evogene 52-week high stock price is 10.40, which is 279.6% above the current share price.
The Evogene 52-week low stock price is 2.72, which is 0.7% below the current share price.
The average Evogene stock price for the last 52 weeks is 6.57.